Do You Really Need to Hold That Meeting?
A simple tool to help you decide.
A simple tool to help you decide.
Key Points. 41% of referrals in the community were unable to access anti-CD19+ CAR-T cells for NHL between 2018-2022Attrition from disease-related factors
In 1957, Dr. A. McGehee Harvey, Chair of the Johns Hopkins Department of Medicine, created a Division of Cancer Research and Treatment with the 31-year-old…
Light The Night At The Leukemia & Lymphoma Society’s Light The Night we gather as a community to celebrate, honor, and remember those touched by…
First transplant program of its kind in HCA Florida Healthcare
Chronic graft-vs-host disease, an immune-mediated disorder that follows allogeneic hematopoietic cell transplantation, is characterized by debilitating tissue injury with inflammatory and fibrotic pat…
One year has passed since this monthly feature in Transplantation and Cellular Therapy was introduced with the goal of sharing the humanistic aspects of our…
One year has passed since this monthly feature in Transplantation and Cellular Therapy was introduced with the goal of sharing the humanistic aspects of our…
This podcast series educates patients, caregivers, and health care professionals regarding important topics as they relate to bone marrow/stem cell transplant and Car-T cellular therapy.…
Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial…
Colorado blood cancer patients benefit from care teams with dep expertise and commitment to the evolution of care.